Literature DB >> 20223325

Infant communicating hydroceles--do they need immediate repair or might some clinically resolve?

Michelle E Koski1, John H Makari, Mark C Adams, John C Thomas, Peter E Clark, John C Pope, John W Brock.   

Abstract

PURPOSE: Infant hydroceles that are communicating by history (fluctuation in size) or examination (reducible fluid) are often repaired soon after presentation. We have followed a series of infant boys with such hydroceles and reviewed their early natural history.
MATERIALS AND METHODS: Since 1998, we have followed 174 infant boys presenting with an apparent communicating hydrocele without immediate surgical repair. All boys were initially seen before 18 months of age and most (168) by 12 months. Most had been full term at delivery, although 32 had been premature (<37 weeks' gestational age) and 11 extremely so (<32 weeks). Most boys (120) had bilateral hydroceles at presentation.
RESULTS: Of the 110 boys followed to disposition, 69 (62.7%) had complete resolution without surgery by a mean age of 11.7 months. Forty-one patients (37.3%) underwent surgery for correction at a mean age of 14 months because of persistence in size or development of a hernia. Six developed a hernia during observation, none of whom had any episode of incarceration. Only 2 patients with apparent resolution subsequently had recurrence with a hernia. Age at presentation and gestational age at birth showed no effect on resolution. The hydroceles of 64 boys had improved in size after a mean follow-up of 13.9 months when last seen.
CONCLUSIONS: Many infant hydroceles that are communicating by history or examination do resolve clinically without surgery and deserve observation. Progression to hernia was rare in our experience and did not result in incarceration. Consequently, little risk is taken by initial observation.

Entities:  

Mesh:

Year:  2010        PMID: 20223325     DOI: 10.1016/j.jpedsurg.2009.06.026

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

Review 1.  Inguinoscrotal pathology.

Authors:  Luis Guerra; Michael Leonard
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 2.  Classifying Hydroceles of the Pelvis and Groin: An Overview of Etiology, Secondary Complications, Evaluation, and Management.

Authors:  Gautam Dagur; Jason Gandhi; Yiji Suh; Steven Weissbart; Yefim R Sheynkin; Noel L Smith; Gargi Joshi; Sardar Ali Khan
Journal:  Curr Urol       Date:  2017-03-30

Review 3.  The challenging sonographic inguinal canal evaluation in neonates and children: an update of differential diagnoses.

Authors:  Yoshino T Sameshima; Maurício G I Yamanari; Mariana A Silva; Miguel J Francisco Neto; Marcelo B G Funari
Journal:  Pediatr Radiol       Date:  2016-11-10

4.  Modified single-port minilaparoscopic extraperitoneal repair for pediatric hydrocele: a single-center experience with 279 surgeries.

Authors:  Zhifeng Wang; Le Xu; Zhi Chen; Cong Yao; Zexuan Su
Journal:  World J Urol       Date:  2014-02-13       Impact factor: 4.226

5.  Current practice regarding timing of patent processus vaginalis ligation for idiopathic hydrocele in young boys: a survey of UK surgeons.

Authors:  Matthew Jobson; Nigel J Hall
Journal:  Pediatr Surg Int       Date:  2017-04-19       Impact factor: 1.827

6.  A challenging abdomino-scrotal hydrocele-successful resolution with the help of interventional radiology guided sclerosis.

Authors:  Joseph Rassam; Andrew E Healey; Sarah J Wood; Harriet Jane Corbett
Journal:  J Surg Case Rep       Date:  2018-09-11

7.  Laparoscopic management of infantile hydrocele in pediatric age group.

Authors:  Ahmed Elhaddad; Mohamed Awad; Sherif M Shehata; Mohamed A Shehata
Journal:  Pediatr Surg Int       Date:  2022-02-06       Impact factor: 1.827

Review 8.  The role of scrotal ultrasonography from infancy to puberty.

Authors:  Matteo Spaziani; Claudio Lecis; Chiara Tarantino; Emilia Sbardella; Carlotta Pozza; Daniele Gianfrilli
Journal:  Andrology       Date:  2021-06-11       Impact factor: 3.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.